TP53 and acute myeloid leukemia: There was a significant increase in the frequency of RUNX1 mutations towards progression/transformation of CMML into AML but no increase in the prevalence of mutations of SETBP1, TET2, EZH2, ASXL1, SRSF2, and TP53.